HCAT
Health Catalyst Inc
NASDAQ: HCAT · HEALTHCARE · HEALTH INFORMATION SERVICES
$2.16
+0.93% today
Updated 2026-07-29
Market cap
$153.70M
P/E ratio
—
P/S ratio
0.51x
EPS (TTM)
$-3.73
Dividend yield
—
52W range
$1 – $4
Volume
1.7M
Health Catalyst Inc (HCAT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$2.16
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -87.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.